Stryker, Mazor Robotics, Xtant Medical & more: 11 key notes

Here are 11 key notes on orthopedic and spine device companies over the past week.

Advertisement

After the Australian government issued a warning about Stryker’s LFIT Anatomic CoCr V40 femoral heads, physician/lawyer Shezad Malik believes a recall could be “imminent.”

 

Mazor Robotics received purchase orders for 25 system orders in the third quarter of 2016, including pre-launch orders for the Mazor X.

 

SpineGuard reported third quarter revenue of €1.7 million, representing a 2 percent increase compared to the third quarter in 2015.

 

Xtant Medical anticipates its third quarter revenue to be between $23 million and $23.3 million.

 

Implanet saw total sales of €5.58 million over the first nine months of the year.

 

Medicrea sales totaled €6.8 million for the third quarter, representing a 3 percent decline compared to the same period in 2015.

 

Titan Spine expanded its commercial launch of the nanoLOCK surface technology throughout the nation.

 

Titan Spine successfully raised $7.5 million in funding from Southlake Equity Group.

 

SpineNevada’s InMotion Diagnostics provides an imaging platform to measure instability through spinal motion.

 
Surgeons performed the first surgery using Gainesville, Fla.-based Exactech’s Vantage Total Ankle System.

 

Exactech performed the first successful revision knee procedure with its guided personalized surgery system.

 

More articles on devices:
35 spine, orthopedic devices receive FD A 510(k) clearance in September 2016
SpineGuard reports €1.7M Q3 2016 revenue — 6 notes
5 observations on how 3D printing is transforming the medical device industry

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.